# Dietary Intervention in Follicular Lymphoma

> **NCT00455416** · PHASE2 · UNKNOWN · sponsor: **Oslo University Hospital** · enrollment: 45 (estimated)

## Conditions studied

- Follicular Lymphoma

## Interventions

- **DRUG:** Omega 3 fatty acids (EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid))
- **DRUG:** Selenium (L-Selenomethionine),
- **DRUG:** Garlic extract (Allicin)
- **DRUG:** Pomegranate juice (ellagic acid)
- **DRUG:** Grape juice (resveratrol, quercetin)
- **DRUG:** Green Tea (Epigallocathechin gallate)

## Key facts

- **NCT ID:** NCT00455416
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** 2009-04
- **Final completion:** 2009-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2008-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00455416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00455416, "Dietary Intervention in Follicular Lymphoma". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00455416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*